News from eip pharma, llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 19, 2017, 05:00 ET EIP Pharma announces presentation of new mechanism of action data regarding neflamapimod (VX-745) at Alzheimer's Association International Conference (AAIC)

EIP Pharma, LLC (www.eippharma.com) today announced that new mechanism of action data regarding neflamapimod were presented at the AAIC 2017...


Jul 18, 2017, 05:00 ET EIP Pharma announces presentation of new positive clinical data with neflamapimod (VX-745) at Alzheimer's Association International Conference (AAIC)

EIP Pharma, LLC (www.eippharma.com) today announced that new clinical data with neflamapimod were presented at the AAIC 2017 scientific meeting in...


Sep 28, 2016, 08:00 ET EIP Pharma announces issuance of multiple new patents covering VX-745, a selective p38 MAP kinase alpha inhibitor for Alzheimer's disease and ischemic stroke recovery

EIP Pharma, LLC (www.eippharma.com) today announced that the U.S. Patent Office issued on August 30, 2016 the following two patents: U.S. Patent No....